Clinical Trials Directory

Trials / Completed

CompletedNCT03747029

Serum Calcium to Phosphorous (Ca/P) Ratio in the Diagnosis of Ca-P Metabolism Disorders: a Multicentre Study

Status
Completed
Phase
Study type
Observational
Enrollment
1,038 (actual)
Sponsor
Azienda Ospedaliero-Universitaria di Modena · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

Primary hyperparathyroidism (PHPT) and Hypoparathyroidism (HP) are two of the most frequent disorder of Calcium-Phosphorus (Ca-P) metabolism. The Ca/P ratio is an accurate tool to differentiate patients with PHPT from healthy subjects, according to a previous single-centre study. The reliability of this index is based on the fact that serum Ca and P are inversely related together either in healthy subjects or in patients with PHPT and HP.

Detailed description

The aim of this study is to investigate the accuracy and diagnostic value of Ca/P ratio in the diagnosis of primary hyperparathyroidism and hypoparathyroidism. The definition of a valid cut-off of serum Ca/P ratio for patients with these disorders will be of help especially in those patients with apparently normal biochemical profile, but suggestive for primary hyperparathyroidism and hypoparathyroidism.

Conditions

Interventions

TypeNameDescription
OTHERNo intervention is providedNo intervention is provided

Timeline

Start date
2017-11-28
Primary completion
2018-12-31
Completion
2018-12-31
First posted
2018-11-20
Last updated
2021-02-09

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT03747029. Inclusion in this directory is not an endorsement.